Diagnostic delay associated with commercial full-body MRI scans
Ugeskrift for Læger · 09.11.2026 · 1-4
DOI: 10.61409/v04260354 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ugeskrift for Læger, online erschienen am 09.11.2026. Verfasst von Mads Gustaf Jørgensen und 2 weiteren Autor:innen.
Abstract (Originalsprache)
While direct-to-consumer whole-body MRI screening is criticised for overdiagnosis, this case report highlights an opposite risk: false reassurance. A case of a 75-year-old man with a 6.7 cm axillary melanoma metastasis found via a self-referred MRI is presented. A similar unindicated scan two years prior revealed a 2.4 cm lymph node but prompted no clinical follow-up. Consequently, massive tumour growth remained unnoticed. This illustrates the danger of separating imaging from clinical responsibility, inducing false reassurance and a two-year diagnostic delay.
Zitieren
APA
Jørgensen, M. G., Hölmich, L. R., & Møller, M. P. (2026). Diagnostic delay associated with commercial full-body MRI scans. Ugeskrift for Læger, 1-4. https://doi.org/10.61409/v04260354
Vancouver
Jørgensen MG, Hölmich LR, Møller MP. Diagnostic delay associated with commercial full-body MRI scans. Ugeskrift for Læger. 2026:1-4. doi:10.61409/v04260354
BibTeX
@article{Jrgensen2026,
author = {Jørgensen, Mads Gustaf and Hölmich, Lisbet Rosenkrantz and Møller, Michael Prangsgaard},
title = {Diagnostic delay associated with commercial full-body MRI scans},
journal = {Ugeskrift for Læger},
year = {2026},
pages = {1--4},
doi = {10.61409/v04260354}
}
EUVIMED